Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillip Good

Showing results (101-110 of 117) with videos related to

Pageof 12
Sort By:
Internal Medicine Journal|August 20, 2019
Supporting choice: an innovative model of integrated palliative care funded by a private health insurerJessica Cross, Amanda Fischer, Donna Shotton, et al.
Journal of Pain and Symptom Management|December 24, 2019
Prevalence of QTc Prolongation in Patients With Advanced Cancer Receiving Palliative Care-A Cause for Concern?Janet R Hardy, Daniel Bundock, Jessica Cross, et al.
Journal of Palliative Care|November 5, 2010
The effectiveness and adverse effects profile of "burst" ketamine in refractory cancer pain: The VCOG PM 1-00 studyKate Jackson, Michael Ashby, Deb Howell, et al.
Neuro-Oncology Practice|June 3, 2015
Culturally and linguistically diverse patient participation in glioma researchZarnie Lwin, Alexander Broom, Rasha Cosman, et al.
Journal of Clinical Epidemiology|October 12, 2010
Aggregating single patient (n-of-1) trials in populations where recruitment and retention was difficult: the case of palliative careJane Nikles, Geoffrey K Mitchell, Philip Schluter, et al.
Trials|May 30, 2024
Correction: Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trialTaylan Gurgenci, Janet Hardy, Georgie Huggett, et al.
Trials|May 1, 2024
Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trialTaylan Gurgenci, Janet Hardy, Georgie Huggett, et al.
Palliative Medicine|May 24, 2015
Testing pilocarpine drops for dry mouth in advanced cancer using n-of-1 trials: A feasibility studyJane Nikles, Geoffrey K Mitchell, Janet Hardy, et al.
BMC Palliative Care|November 2, 2013
Do pilocarpine drops help dry mouth in palliative care patients: a protocol for an aggregated series of n-of-1 trialsJane Nikles, Geoffrey K Mitchell, Janet Hardy, et al.
Journal of Pain and Symptom Management|April 22, 2015
The Effect of Methylphenidate on Fatigue in Advanced Cancer: An Aggregated N-of-1 TrialGeoffrey K Mitchell, Janet R Hardy, Catherine J Nikles, et al.
Pageof 12

Showing results (101-110 of 117) with videos related to

Sort By:
Pageof 12
Internal Medicine Journal|August 20, 2019
Supporting choice: an innovative model of integrated palliative care funded by a private health insurerJessica Cross, Amanda Fischer, Donna Shotton, et al.
Journal of Pain and Symptom Management|December 24, 2019
Prevalence of QTc Prolongation in Patients With Advanced Cancer Receiving Palliative Care-A Cause for Concern?Janet R Hardy, Daniel Bundock, Jessica Cross, et al.
Journal of Palliative Care|November 5, 2010
The effectiveness and adverse effects profile of "burst" ketamine in refractory cancer pain: The VCOG PM 1-00 studyKate Jackson, Michael Ashby, Deb Howell, et al.
Neuro-Oncology Practice|June 3, 2015
Culturally and linguistically diverse patient participation in glioma researchZarnie Lwin, Alexander Broom, Rasha Cosman, et al.
Journal of Clinical Epidemiology|October 12, 2010
Aggregating single patient (n-of-1) trials in populations where recruitment and retention was difficult: the case of palliative careJane Nikles, Geoffrey K Mitchell, Philip Schluter, et al.
Trials|May 30, 2024
Correction: Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trialTaylan Gurgenci, Janet Hardy, Georgie Huggett, et al.
Trials|May 1, 2024
Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trialTaylan Gurgenci, Janet Hardy, Georgie Huggett, et al.
Palliative Medicine|May 24, 2015
Testing pilocarpine drops for dry mouth in advanced cancer using n-of-1 trials: A feasibility studyJane Nikles, Geoffrey K Mitchell, Janet Hardy, et al.
BMC Palliative Care|November 2, 2013
Do pilocarpine drops help dry mouth in palliative care patients: a protocol for an aggregated series of n-of-1 trialsJane Nikles, Geoffrey K Mitchell, Janet Hardy, et al.
Journal of Pain and Symptom Management|April 22, 2015
The Effect of Methylphenidate on Fatigue in Advanced Cancer: An Aggregated N-of-1 TrialGeoffrey K Mitchell, Janet R Hardy, Catherine J Nikles, et al.
Pageof 12